Pregled bibliografske jedinice broj: 195953
22q11.2 deletion in a series of paediatric at risk patients
22q11.2 deletion in a series of paediatric at risk patients // Abstracts of the ..... ; u: European Journal of Human Henetics. Supplement 13 (2005) (S1), 2005. str. 100-100 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 195953 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
22q11.2 deletion in a series of paediatric at risk patients
Autori
Barišić, Ingeborg ; Petković, Iskra ; Morožin-Pohovski, Leona ; Cvetko, Željko ; Stipančić, Gordana ; Bagatin, Mario
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the ..... ; u: European Journal of Human Henetics. Supplement 13 (2005) (S1)
/ - , 2005, 100-100
Mjesto i datum
,
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
22q11.2 deletion; FISH; molecular cytogenetics
Sažetak
22q11.2 deletion syndrome is a common disorder typically consisting of dysmorphic facies, congenital heart defects (CHD), hypoparathyroidism, immunodefeiciency and palate abnormalities. The associated phenotypic manifestations are extensive, highly variable from patient to patient and age-dependent. Patients with mild clinical manifestations presenting with apparently isolated malformation or dysmorphic traits can be easily overlooked. To find out if the 22q11.2 deletion studies should become a part of a standardized diagnostic workup for patients presenting with isolated defects of with dysmorphic traits alone. We prospectively studied the frequency of 22q11.2 deletion in an unselected population of 171 patients aged 4 days to 18 years referred because of : 1. CHD (64) 2. cleft palate (58) 3. hypocalcemia (18) 4. dysmorphic features suggestive of del22q11.2 (31). Detailed clinical evaluation, high-resolution chromosome and FISH analysis were performed. Results: FISH analysis revealed 22q11.2 deletion in 9.4% (6/64) patients with CHD. In the subgroup of patients with conotruncal anomalies del22.q11.2 was present in 17.8% (5/28) patients. From 18 patients referred because of the hypocalcaemia, 6 had 22q11.2 deletion (33.3%). In the group of 31 patients with dysmorphic features, the diagnosis was confirmed in two patients (6.4%). Testing for the 22q11.2 microdeletion can be recommended in all patients with conotruncal heart defects and in patients with hypocalcaemia. It could be considered in patients presenting with at least 3 dysmorphic traits suggestive of 22q11.2 microdeletion syndrome. A routine screening for the 22q11 deletion patients with and isolated palatal defect may not be warranted.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Napomena
Podatak o skupu? Admin (2007-08-08).
POVEZANOST RADA
Projekti:
0072165
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta,
KBC "Sestre Milosrdnice",
Klinička bolnica "Dubrava"
Profili:
Mario Bagatin
(autor)
Iskra Petković
(autor)
Ingeborg Barišić
(autor)
Gordana Stipančić
(autor)
Željko Cvetko
(autor)
Leona Morožin Pohovski
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE